BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1360862)

  • 1. Genetically epilepsy-prone rats have increased brain regional activity of an enzyme which liberates glutamate from N-acetyl-aspartyl-glutamate.
    Meyerhoff JL; Carter RE; Yourick DL; Slusher BS; Coyle JT
    Brain Res; 1992 Oct; 593(1):140-3. PubMed ID: 1360862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate: subcellular and regional distribution, ontogeny, and the effect of lesions on N-acetylated-alpha-linked acidic dipeptidase activity.
    Blakely RD; Robinson MB; Thompson RC; Coyle JT
    J Neurochem; 1988 Apr; 50(4):1200-9. PubMed ID: 3346674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seizures decrease regional enzymatic hydrolysis of N-acetyl-aspartylglutamate in rat brain.
    Meyerhoff JL; Robinson MB; Bixler MA; Richards SS; Coyle JT
    Brain Res; 1989 Dec; 505(1):130-4. PubMed ID: 2611666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive inhibition of N-acetylated-alpha-linked acidic dipeptidase activity by N-acetyl-L-aspartyl-beta-linked L-glutamate.
    Serval V; Barbeito L; Pittaluga A; Cheramy A; Lavielle S; Glowinski J
    J Neurochem; 1990 Jul; 55(1):39-46. PubMed ID: 2355230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical localization of the N-acetyl-aspartyl-glutamate (NAAG) hydrolyzing enzyme N-acetylated alpha-linked acidic dipeptidase (NAALADase).
    Slusher BS; Tsai G; Yoo G; Coyle JT
    J Comp Neurol; 1992 Jan; 315(2):217-29. PubMed ID: 1545010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases.
    Passani LA; Vonsattel JP; Carter RE; Coyle JT
    Mol Chem Neuropathol; 1997 Jun; 31(2):97-118. PubMed ID: 9376025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains.
    Tsai G; Passani LA; Slusher BS; Carter R; Baer L; Kleinman JE; Coyle JT
    Arch Gen Psychiatry; 1995 Oct; 52(10):829-36. PubMed ID: 7575102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of N-acetylated alpha-linked acidic dipeptidase (NAALADase) inhibitors on [3H]NAAG catabolism in vivo.
    Stauch BL; Robinson MB; Forloni G; Tsai G; Coyle JT
    Neurosci Lett; 1989 May; 100(1-3):295-300. PubMed ID: 2668802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regional distribution of N-acetylaspartylglutamate (NAAG) and peptidase activity against NAAG in the rat nervous system.
    Fuhrman S; Palkovits M; Cassidy M; Neale JH
    J Neurochem; 1994 Jan; 62(1):275-81. PubMed ID: 8263527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated alpha-linked acidic dipeptidase.
    Jackson PF; Cole DC; Slusher BS; Stetz SL; Ross LE; Donzanti BA; Trainor DA
    J Med Chem; 1996 Jan; 39(2):619-22. PubMed ID: 8558536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylaspartylglutamate catabolism is achieved by an enzyme on the cell surface of neurons and glia.
    Cassidy M; Neale JH
    Neuropeptides; 1993 May; 24(5):271-8. PubMed ID: 8100987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo inhibition of N-acetyl-L-aspartyl-L-glutamate catabolism by N-acylated L-glutamate analogs.
    Serval V; Galli T; Cheramy A; Glowinski J; Lavielle S
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1093-100. PubMed ID: 1545381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase.
    Carter RE; Feldman AR; Coyle JT
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):749-53. PubMed ID: 8570628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain.
    Robinson MB; Blakely RD; Couto R; Coyle JT
    J Biol Chem; 1987 Oct; 262(30):14498-506. PubMed ID: 3667587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of glutamate carboxypeptidase II (NAALADase) enzyme activity by the hydrolysis of [³H]-N-acetylaspartylglutamate (NAAG).
    Tiffany CW; Slusher BS
    Curr Protoc Pharmacol; 2002 Feb; Chapter 3():Unit3.10. PubMed ID: 21959764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Acetylated alpha-linked acidic dipeptidase converts N-acetylaspartylglutamate from a neuroprotectant to a neurotoxin.
    Thomas AG; Vornov JJ; Olkowski JL; Merion AT; Slusher BS
    J Pharmacol Exp Ther; 2000 Oct; 295(1):16-22. PubMed ID: 10991955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptosomal transport of radiolabel from N-acetyl-aspartyl-[3H]glutamate suggests a mechanism of inactivation of an excitatory neuropeptide.
    Blakely RD; Ory-Lavollée L; Thompson RC; Coyle JT
    J Neurochem; 1986 Oct; 47(4):1013-9. PubMed ID: 2875126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetyl-aspartyl-glutamate (NAAG) elicits rapid increase in intraneuronal Ca2+ in vitro.
    Koenig ML; Rothbard PM; DeCoster MA; Meyerhoff JL
    Neuroreport; 1994 May; 5(9):1063-8. PubMed ID: 8080959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal acidic amino acids and N-acetylaspartylglutamate in hereditary canine motoneuron disease.
    Tsai G; Cork LC; Slusher BS; Price D; Coyle JT
    Brain Res; 1993 Dec; 629(2):305-9. PubMed ID: 8111634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of NAALADase: a novel neuroprotective strategy based on limiting glutamate and elevating NAAG.
    Vornov JJ; Wozniak K; Lu M; Jackson P; Tsukamoto T; Wang E; Slusher B
    Ann N Y Acad Sci; 1999; 890():400-5. PubMed ID: 10668445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.